Delle Donne Biotech Fund, a Series of Vauban Platform LP — Form D
Delle Donne Biotech Fund, a Series of Vauban Platform LP of MIDDLETOWN, DE, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-10-02. The offering totals $511K, of which $511K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-10-02
- Form: D
- Accession: 0001995181-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $511K
- Amount sold: $511K
- Minimum investment: $1K
- Investors: 34
- Date of first sale: 2023-09-20
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-493606
Issuer
- Name: Delle Donne Biotech Fund, a Series of Vauban Platform LP
- CIK: 0001995182
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: C/O LEGALINC CORPORATE SERVICES, MIDDLETOWN, DE, 19709
- Phone: 434 238 0920
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Charley Shozen Kevers | Executive Officer | New York, NY |
| Henry Shozen Ward | Executive Officer | New York, NY |
| NA Vauban Advisers LLC | Promoter | New York, NY |
| NA Vauban Capital GP LLC | Promoter | New York, NY |
More